Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Dec 28, 2023
$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge

$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge

Robots for this group tickers :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) - 30-day Annualized Return +209%
Swing Trader, Popular Stocks: Price Action Trading Strategy - Pro Version (TA&FA) - 30-day Annualized Return +182%

Recently, Women's Health companies have taken center stage, showcasing a remarkable +14.83% increase in performance over the past week. This surge is backed by three key players in the sector - AWH (Aspira Women's Health), AGRX (Agile Therapeutics), and RDUS (Radius Health).

Positive Outlook and Volume Indicators: Today, stocks in the Women's Health group maintain a positive outlook, supported by robust Volume Indicators. Tickeron, a leading market analysis platform, predicts a further increase of over 4.00% within the next month, with a 63% likelihood. The daily ratio of advancing to declining volumes in the past month was an impressive 4.35 to 1.

Advances Indicator and Positive Trends: A closer look at the Advances Indicator reveals a consistent positive trend across three stocks in this thematic group, with an average likelihood of 82%. This suggests a prevailing sentiment of growth and stability among investors.

Market Capitalization Insights: The market capitalization within the Women's Health Theme averages at 245.7M. RDUS stands out with the highest valuation in this group, reaching an impressive 697.4M. In contrast, AGRX holds the position of the lowest valued company at 5.2M.

Price Movements: Weekly, the average price growth for all stocks in the Women's Health Theme was a significant 14.83%. AWH spearheaded this growth with a remarkable 43.89% increase, while AGRX experienced a notable dip at -2.99%. The monthly and quarterly averages stood at 10.55% and -4.59%, respectively.

Notable News and Price Movements:

  • AWH made headlines as the top weekly gainer, rising by 26.79% on 8/15/23, and also faced a significant drop of -36.68% on 7/27/23.
  • AGRX, on 10/7/23, saw a sharp decline of -20.83%, marking it as a top weekly loser.
  • RDUS, on 12/26/23, continued an uptrend, experiencing a +22% increase during the month of 11/22/23 - 12/26/23.

Volume Growth: While the average weekly volume growth across all stocks in the Women's Health Theme was -1.08%, monthly and quarterly figures painted a different picture with 164.37% and 19.64% growth, respectively. Notable record-breaking daily volume increases were observed for AWH, AGRX, and RDUS, emphasizing heightened market activity.

Technical Analysis Highlights:

  1. AWH: The 50-day moving average crossed bearishly below the 200-day moving average on December 11, 2023. Despite this, the stock has shown resilience, with a recent uptrend of +28% during the week of 12/18/23 - 12/26/23.

  2. AGRX: The RSI Oscillator for AGRX moved out of the overbought zone on December 05, 2023, suggesting a potential shift from an upward to a downward trend. The odds of a move down, according to Tickeron's analysis, stand at 90%.

  3. RDUS: Displaying a +1.52% uptrend, RDUS advanced for three consecutive days on December 26, 2023. Historical data indicates a 75% likelihood of continued upward momentum.

Summary: The Women's Health sector, led by AWH, AGRX, and RDUS, is currently in a phase of dynamic growth, supported by positive market indicators and technical analyses. Investors should keep a keen eye on these stocks, considering the theme's potential for further expansion in the coming months.

Related Ticker: AWHL, AGRX, RDUS

Contributor

Dem Sem's AvatarDem Sem|Expert

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of bio-analytic and diagnostic services and helps physicians diagnose, treat, and improve gynecologic health outcomes for women

Industry MedicalSpecialties

Industry
Multi Line Insurance
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.